![BeardBros_BlogImages [Recovered]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjU2MCAyOTIiIHdpZHRoPSIyNTYwIiBoZWlnaHQ9IjI5MiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48L3N2Zz4=)
Key Takeaways
- The Senate’s continuing resolution delays the federal hemp ban until December 11, 2026, but only for certain products; synthetic cannabinoids do not receive this protection.
- The House version of the continuing resolution lacks any hemp provisions, creating potential legal complications for the hemp industry.
- If the December deadline passes without a fix, approximately 95% of hemp-derived cannabinoid products may become illegal under the new THC threshold.
- The industry values the hemp-derived cannabinoid market at around $28 billion and fears significant job losses without regulatory adjustments.
- Congress aims to reach a long-term solution for hemp regulations, but uncertainty remains as negotiations continue in September.
The hemp industry has been watching Congress closely all year, and on Sunday, that attention finally produced something worth talking about. Senate Appropriations Committee leaders released the text of a stopgap funding bill designed to keep the federal government running past the September 30 fiscal year deadline and push budget negotiations until after the midterm elections. Tucked inside that legislation is a provision that directly affects every hemp business in the country. Section 2019 of the Senate’s continuing resolution would delay the federal hemp THC ban from November 12 to December 11, 2026.
That is 29 days. Not a permanent fix, not a new regulatory framework, but 29 days that could mean the difference between an orderly wind-down and a chaotic scramble for manufacturers, retailers, and distributors sitting on existing inventory. There is an important catch, and it matters for certain operators. The delay does not protect all hemp products equally. Here is where things get specific, and where hemp businesses need to read carefully before assuming they are covered.
What the Senate CR Hemp Provision Actually Says
The Senate’s continuing resolution contains Section 2019, which limits the reach of Section 781 of Public Law 119-37 until December 11, 2026. Section 781 is the legislation signed late in 2025 that redefined hemp to make only products containing 0.4 milligrams of total THC per container federally legal after November 12. That threshold is dramatically lower than the previous standard set by the 2018 Farm Bill, which allowed hemp derivatives containing less than 0.3 percent delta-9 THC on a dry-weight basis.
The Senate CR essentially pauses that new definition for most hemp products. But there is a carve-out. Synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant” do not benefit from the delay. Those products still face recriminalization on November 12, regardless of whether the CR passes. Businesses selling products built around fully synthetic cannabinoids should not count this provision as protection.
For the hemp-derived cannabinoid market, including delta-8, delta-9, CBD, and full-spectrum products derived from the cannabis plant, the Senate language would buy nearly a month of breathing room while Congress continues debating a longer-term approach.
Why the House Version Is a Problem for Hemp Right Now
Here is the part that keeps the situation unresolved. Last month, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded. That bill did not include any language altering the planned hemp product restriction.
That matters. For the Senate’s hemp delay to become law, the two chambers need to agree on a single version of the CR. That means the Senate must pass its version, the House must then accept the Senate’s language or negotiate a compromise, and the president must sign it. Each of those steps carries some degree of uncertainty.
Jonathan Miller, general counsel for the U.S. Hemp Roundtable, described the Senate move as potentially “our biggest win since the 2018 Farm Bill legalized hemp,” but immediately noted that the work is not finished. “We will be deeply engaged in ensuring that the current language is retained through the Senate and House CR votes,” Miller said.
Senate leaders planned an initial procedural vote for for this week, with a goal of passing the bill before senators leave for a five-week recess. The House then faces the decision of whether to take up the Senate’s version when lawmakers return in September.
While advocates rally behind the progress made toward securing a hemp extension, not all lawmakers are on board with these developments. GOP Senator Ted Budd has introduced an amendment aimed at blocking any efforts to extend the legality of hemp-derived THC products.
Before the Senate adjourns, we must pass the SAVE America Act, confirm @POTUS's outstanding noms, & fund the govt.
— Senator Ted Budd (@SenTedBuddNC) August 3, 2026
I'm offering an amendment to the CR to strip out an extension of the hemp loophole to ensure unregulated, dangerous intoxicants are not sold, especially to kids.
What Is at Stake for the Hemp Industry If November 12 Arrives Without a Fix
The scale of what is riding on this timeline is significant. Industry groups estimate the hemp-derived cannabinoid market represents approximately $28 billion in annual market value and supports more than 300,000 jobs. Analysts valued the hemp market at approximately $11 billion in 2025 and projected it to grow to $47 billion by 2032, before the restriction became law.
Section 781 of the 2026 Appropriations Act would render approximately 95% of hemp-derived cannabinoid products federally unlawful under the new 0.4 milligram per container threshold. That is not a minor regulatory adjustment. For most hemp businesses operating today, it would effectively eliminate their product lines under federal law.
The consumer side of that equation is just as striking. According to President Trump’s own public statements on the matter, one in five American adults used hemp-derived CBD in the past year. A separate NuggMD poll, shared by Marijuana Moment, found that state-level hemp bans already in place are driving consumers toward licensed marijuana dispensaries rather than eliminating demand altogether.
Which Hemp Products Would Still Be Restricted on November 12 Under the Senate Version?
Even if the Senate CR passes exactly as written, not every hemp product gets the same treatment. On November 12, new laws will recriminalize synthetic cannabinoids that the cannabis plant cannot naturally produce.
This carve-out is not accidental. Lawmakers on both sides of the aisle have drawn a clearer line between plant-derived hemp compounds and fully synthetic analogs, and the CR language reflects that distinction. If your product relies on cannabinoids that have no natural analog in Cannabis sativa L., the Senate delay does not apply. Those products face the November 12 deadline regardless of how the CR vote goes.
For everyone else, the Senate version preserves the status quo until December 11. When the CR expires, the government funding question returns to Congress, creating another legislative moment where lawmakers could attach a more comprehensive hemp fix to a broader spending package.
Where Does Congress Go from Here on Hemp Regulation?
The CR delay, if it becomes law, is not the end of the story. It is a bridge to December, and what happens in December remains an open question. Several legislative proposals have been circulating in both chambers that would do more than pause the restriction.
Rep. Andy Barr (R-KY) filed a bipartisan bill to prevent federal hemp recriminalization outright while putting a regulatory framework in place covering manufacturing, labeling, sales, taxation, and an age limit of 21. The bill is cosponsored by Rep. Angie Craig (D-MN). Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating a separate proposal that would also delay the ban and establish packaging requirements, testing rules, and age restrictions.
Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) are preparing to introduce a companion bill to Barr’s proposal in the Senate. Sheehy has publicly called hemp legislation an area where both parties can find common ground.
“Brewers, farmers, small businesses, and customers in Minnesota have made clear that the federal ban on hemp products will be devastating,” Klobuchar said. “The new government funding bill in the Senate includes a key provision based on my bipartisan bill to delay the federal hemp ban, which I opposed last November, so other states can put more sensible safety rules in place like we have in Minnesota. This delay was immediately necessary to give Minnesota hemp producers and customers certainty, while giving Congress more time to get to a long-term fix.”
None of those longer-term proposals have cleared committee yet. Lawmakers now see the December funding deadline as the most realistic window to attach a broader hemp fix to legislation that has actual momentum behind it.
What Should Hemp Businesses Do With the 29 Days?
Twenty-nine days is a short runway, but it is not nothing. For hemp operators, the practical implications of the Senate CR passing are straightforward. If the delay holds, you have until December 11 before the 0.4 milligram per container threshold takes effect on qualifying plant-derived products. That window covers inventory decisions, supplier contracts, retail distribution agreements, and employee payroll planning.
The U.S. Hemp Roundtable and Hemp Supporter have both signaled that an advocacy campaign is coming this week to build congressional support for retaining the Senate language through the House vote. Industry stakeholders who want to influence that outcome have a narrow window to make their voices heard.
What businesses should not do is treat the Senate CR language as a done deal. The House still has to accept it. That negotiation will happen in September, and the hemp provision is one of many contested elements in a bill that covers everything from immigration enforcement funding to grant approval processes. Negotiators could keep the hemp delay intact, strip it out entirely, or use it as a bargaining chip.
Frequently Asked Questions
Senate Appropriations leaders included language in a continuing resolution released on August 2, 2026, that would delay the federal hemp THC product ban from November 12 to December 11, 2026. The provision is in Section 2019 of the bill and applies to most plant-derived hemp cannabinoid products. It does not extend to synthetic cannabinoids that cannot be naturally produced by a Cannabis sativa L. plant.
No. The Senate CR is not yet law. The Senate must first pass the bill, then the House must agree to the same language, and the president must sign it. The House passed its own version of the continuing resolution last month without any hemp delay provisions, meaning the two chambers must reach an agreement before anything changes.
The Senate’s continuing resolution explicitly excludes synthetic cannabinoids that the cannabis plant cannot naturally produce. Those products still face federal recriminalization on November 12, 2026, regardless of how the CR vote turns out.
The continuing resolution funds the federal government and delays hemp regulations until December 11, 2026. When funding negotiations reopen in December, lawmakers may have an opportunity to attach a longer-term hemp regulatory solution to a broader spending package.
